Press Release

Clinical Trial Re-Confirms Role of Oral Bacteriotherapy in Hospitalized Covid-19 Patients

Lausanne, Switzerland, January 20, 2021 — Ormendes is proud to announce the results, now published in Frontiers in Nutrition, of an Italian retrospective clinical study confirming reduced mortality of hospitalized COVID-19 patients with severe pneumonia when supplemented with Sivomixx®800. 

Learn more

Bacteriotherapy shows promise as a complementary therapeutic strategy to avoid the progression of COVID-19

Lausanne, Switzerland, July 8th 2020 — Ormendes SA is proud to announce that Sivomixx®800, one of its probiotic formulations has been used in a clinical study to supplement Covid-19 patients in addition to their standard care, the results of which have now been published in Frontiers in Medicine.

Learn more

Consult the experts

For any questions, contact us via email using the form provided for this purpose.

Contact us